We're taking an indefinite break from Twitter/X. Find us on Bluesky and LinkedIn. Keep up to date with our work through our website https://t.co/1P8pH8mYrR
At carafem, we’ve seen firsthand how "missed period pills" can help people take control of their reproductive health through a study we participated in with @Gynuity, no confirmation of pregnancy required.
A double dose of the emergency contraceptive ella along with #misoprostol is effective for early abortion, says new study from @Gynuity . @Plancpills https://t.co/A5OFyzFN6t
📢 Data from a small study suggest ulipristal acetate plus #misoprotol was effective and safe for early #medicationabortion up to 63 days’ gestation, 💊 but more research is needed.
@NEJMEvidence@Gynuity
https://t.co/NLsG2qAY8n
Induction of labor is an increasingly common intervention but experiences & preferences of induction methods are under-researched. Understanding these perspectives is important to improve the childbirth experience: https://t.co/DMojOePcSK in @AjogGlobal
🧐https://t.co/RoYH14ALbT
➡️Published studies on #telemedicine medication #abortion & labor induction with oral #misoprostol for #hypertension in pregnancy
➡️Ongoing research on alternative abortifacients, ‘period pill’ regimens & a #postpartum self-care monitoring app
Spoiler Alert. #Telemedicine medication abortion without in-person tests is safe, feasible and acceptable, according to our study in Ukraine, Uzbekistan, and Azerbaijan >> https://t.co/pUlYvaMlM3
Today is #WorldPreeclampsiaDay. Check out the latest evidence on the use of low-dose oral #misoprostol tablets for labor induction in pregnancies complicated by #hypertension. Randomized trial results hot off the press➡️ https://t.co/eM7QcxUfDn
A study published in #BMCMedResMethodol introduces PaGES: a Participant-Generated Experience and Satisfaction Index, a new Patient-Reported Outcomes or Experience Measures (PROMS/PREMS) evaluation tool. https://t.co/TciFXOtYYI
We're delighted to add Tanzania to our Map of #Mifepristone Approvals—https://t.co/lH7ObSWBib. We congratulate everyone involved in getting mifepristone approved, a decision that will help strengthen access to #reproductive healthcare options for individuals in Tanzania.
In a conversation w/ @themeteor, the Council's @lisabhaddad & @Gynuity's Beverly Winikoff discuss #mifepristone, the politics behind targeting the FDA’s approval of the abortion pill, & how the #SCOTUS decision may impact #reprohealth in the US.
Read: https://t.co/yEZslKjPsE
👉🏽Beverly Winikoff @Gynuity: "no matter the outcome at the Supreme Court, medication abortion is here to stay" 💚via @andrew_chung_@Reuters
https://t.co/nggqIrXVfv
🧐https://t.co/z25yY8oeDt
👉Medication abortion screening by computer
👉Experiences & satisfaction with childbirth tool
👉Assessing misoprostol-only for #telemedicine#medicationabortion
👉Reproductive health #self-care in humanitarian & fragile settings
👉#SCOTUS amicus brief
👏👏👏Senators in France overwhelmingly approve the inclusion in the Constitution of the "guaranteed freedom" of women "to have recourse to a voluntary termination of pregnancy", paving the way for final adoption of the text in Congress next month.
We applaud Ecuador's Ministry of Health for successfully including mifepristone in its National Essential Medicines List, as well as those who helped make it happen.
Map available in Spanish https://t.co/IndS8uDDAh